5 ballot items.
Five management proposals to adopt an Amended and Restated Certificate of Incorporation to (1) increase authorized common shares from 90,000,000 to 180,000,000, (2) add officer exculpation permitted by Delaware law, (3) add Delaware and federal forum-selection provisions, (4) permit holders of affected preferred series to vote on amendments relating solely to those series, and (5) remove outdated board declassification provisions and make ministerial updates including indemnification clarifications and a severability clause.
Amend and restate the Certificate of Incorporation to increase authorized common stock from 90,000,000 to 180,000,000 shares to provide flexibility for capital raising, equity awards, acquisitions, and other corporate purposes.
This proposal asks shareholders to approve an amendment and restatement of the Company’s Certificate of Incorporation to double the authorized common stock from 90 million to 180 million shares by revising SECTION 1 of ARTICLE IV. Management seeks this authorization to provide the Board with additional flexibility for capital raising (public or private offerings), to issue equity in connection with acquisitions or strategic transactions, and to ensure sufficient authorized shares are available for equity compensation grants to recruit and retain talent. The filing discloses that, as of August 5, 2026, approximately 82.58 million shares were outstanding and only about 370,147 shares remained unreserved and available, with significant reservation levels for existing equity awards and warrants, creating a practical constraint on future grants and transactions. The Board frames the change as driven by business needs rather than an immediate issuance plan, but it acknowledges the additional authorized shares could be issued without further shareholder approval (subject to law and Nasdaq rules), which could dilute existing holders and potentially be used in ways that affect control. The proxy statement warns of potential adverse effects—reducing earnings per share, book value per share and voting power—and notes the theoretical possibility of anti-takeover use, though it states that dilution is not the purpose of the proposal. Approval would be by a majority of votes cast (routine matter under NYSE rules), and the Board recommends a “For” vote emphasizing strategic flexibility and compensation needs while disclosing dilution risks. Investors should weigh near-term dilution and governance implications against management’s stated financing and talent retention rationales and monitor any subsequent issuances following approval.
Amend Article VIII to extend exculpation protections to officers to the extent permitted by Section 102(b)(7) of the Delaware General Corporation Law, subject to enumerated exceptions (duty of loyalty, bad faith/knowing violations, improper personal benefit, and claims brought by or in the right of the Corporation).
The proposal would expand the Company’s existing director exculpation to include officers to the extent permitted by Delaware law (Section 102(b)(7) as amended). Management asserts that this change is necessary to align the charter with the DGCL amendment effective August 1, 2022, and to provide officers with protection from monetary liability for duty-of-care claims, which the Board believes facilitates timely decision-making and helps attract and retain experienced executives. The charter language preserves key limits: officers remain liable for breaches of the duty of loyalty, acts or omissions not in good faith or involving intentional misconduct or knowing legal violations, transactions conferring improper personal benefit, and claims brought by or in the right of the Company (derivative actions). The amendment is not retroactive to acts or omissions before the effective date and would allow officers to benefit from future DGCL changes without further charter amendments. Board rationale includes reducing frivolous litigation naming officers and lowering related insurance/indemnification costs, while preserving equitable remedies and derivative claims. From a governance perspective, investors must balance improved executive recruitment and reduced litigation risk against concerns that expanded exculpation could diminish personal accountability for some mistake-based harms; however, the preserved exceptions mitigate many accountability concerns. The Board recommends a “For” vote, framing the measure as limited, customary among Delaware corporations, and in shareholders’ long-term interests.
Add a new Article IX to designate Delaware Court of Chancery (and, if necessary, Delaware federal or Superior Court) as the exclusive forum for internal corporate claims and designate U.S. federal district courts as the exclusive forum for claims arising under the Securities Act of 1933.
This proposal would add dual forum-selection provisions to the Company’s charter: (i) designate Delaware’s Court of Chancery as the exclusive forum for internal corporate disputes (with Delaware federal or Superior Court as fallback) and (ii) designate federal district courts as the exclusive forum for claims under the Securities Act. Management argues these provisions concentrate complex corporate litigation in courts with specialized expertise (Delaware chancery and federal courts), promote efficient, predictable outcomes, and can limit duplicative multi‑jurisdiction litigation or forum shopping. The filing cites precedent and Delaware Supreme Court support for the facial validity of federal forum provisions, and the Board notes that stockholder approval can strengthen enforceability. Potential downsides include limiting plaintiffs’ forum choice, possible increased costs to plaintiffs, and uncertainty whether courts in other jurisdictions will enforce federal-forum clauses; if unenforceable, litigation over the clause may itself create expense and delay. The Board presents this as prospective risk mitigation (not in response to any pending suit) and retains the ability to consent to alternative forums when appropriate. Investors should assess whether the governance benefits (predictability, judicial expertise, administrative efficiency) outweigh potential access‑to‑justice and contestability concerns; the Board recommends a “For” vote.
Amend Article IV, Section 2 to provide that amendments to the Certificate of Incorporation that relate solely to one or more outstanding series of preferred stock will be subject to a vote of the holders of those affected preferred series (voting as a class or with affected series), rather than a vote of common stockholders.
This proposal would change voting rules in the charter to provide that amendments affecting solely the terms of one or more outstanding preferred-stock series need not be submitted to a common‑stock vote if holders of the affected preferred series are entitled to vote on the amendment. Management frames the change as clarifying and aligning the charter with Delaware law and common corporate practice, reflecting that holders of a given preferred series are the parties most directly impacted by changes to that series’ rights. The amendment can streamline corporate action by avoiding unnecessary common-stock votes on series-specific matters and reduce transactional friction when adjusting preferred terms under applicable law and existing certificates of designation. Potential investor concerns include reduced oversight by common shareholders over changes that could indirectly affect common equity value; however, the measure preserves applicable-law protections and certificate-of-designation voting where required. The Board recommends a “For” vote; approval is by a majority in voting power of shares entitled to vote on the proposal, and the Board emphasizes the change is intended to respect the separate economic and voting interests of preferred holders.
Amend Article V Sections 3 and 5 to reflect that directors are elected for one‑year terms (board declassification completed) and update indemnification language (clarifying DGCL Section 145(f) effects) and add a severability provision along with other ministerial edits.
This proposal would remove obsolete language relating to the prior declassification of the Board and update the charter for current governance and legal clarity. Management explains that stockholders previously approved declassification and that the charter still contains legacy provisions describing staged declassification; the proposed amendments restate SECTION 3 and SECTION 5 to reflect that directors are elected for one‑year terms and clarify how vacancies are filled, aligning the charter with the post‑declassification reality. The proposal also includes ministerial amendments—clarifying indemnification in light of DGCL Section 145(f) developments and adding a severability clause—to reduce ambiguity and ensure indemnification provisions cannot be retroactively repealed in ways that impair rights tied to particular acts or omissions. The Board frames these as housekeeping measures intended to modernize and harmonize charter text with applicable law and corporate practice; the changes should not meaningfully alter substantive governance rights but will reduce confusion for investors and management. Because approval requires a 66 2/3% supermajority of outstanding common stock, the proposal represents a higher threshold and management highlights that the changes are non‑controversial and ministerial. Investors should note the vote standard and confirm the final amended charter as filed; the Board recommends a “For” vote.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Legion Partners Asset Management, LLCActivist | 5.78% | 4,773,147 | $17M |
| 2 | FIRST MANHATTAN CO. LLC. | 4.00% | 3,303,800 | $12M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.47% | 2,037,299 | $7M |
| 4 | SG Americas Securities, LLC | 2.35% | 1,940,505 | $7M |
| 5 | NOMURA HOLDINGS INC | 2.18% | 1,796,659 | $6M |
| 6 | TWO SIGMA INVESTMENTS, LP | 2.01% | 1,663,043 | $6M |
| 7 | Register Financial Advisors LLC | 1.69% | 1,393,406 | $5M |
| 8 | Corre Partners Management, LLCActivist | 1.50% | 1,238,637 | $4M |
| 9 | MORGAN STANLEY | 1.31% | 1,078,738 | $4M |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 1.17% | 966,000 | $3M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.